MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
von Kesserü E et al. | Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. | 2000 | Contraception | pmid:10906502 |
Kovacs GT et al. | A pre-coital pill? A preliminary in vitro study. | 2000 | Br J Fam Plann | pmid:10920297 |
Dexeus S and Fernández-Cid A | [Cytological changes produced by anovulatories and intrauterine devices]. | 1975 | Acta Ginecol (Madr) | pmid:1092123 |
Garza-Flores J and Stafford JE | Solid-phase radioimmunoassay for norethisterone. | 1979 | Clin. Chim. Acta | pmid:109237 |
Chaudhury RR | Modern trends in contraceptive pharmacology. | 1975 | J Med Assoc Thai | pmid:1094081 |
Grant C et al. | Management of menorrhagia in primary care-impact on referral and hysterectomy: data from the Somerset Morbidity Project. | 2000 | J Epidemiol Community Health | pmid:10942454 |
Flodgaard D et al. | Two oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial. | 1975 | Contraception | pmid:1095298 |
Symons J et al. | Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators. | 2000 | Obstet Gynecol | pmid:10960627 |
Kurman RJ et al. | Norethindrone acetate and estradiol-induced endometrial hyperplasia. | 2000 | Obstet Gynecol | pmid:10960628 |
Kamischke A et al. | Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function. | 2000 | Clin. Endocrinol. (Oxf) | pmid:10971453 |